KORU Medical president buys 12,500 KRMD shares
KORU Medical Systems, Inc. President and Chief Commercial Officer Adam R. Kalbermatten reported open-market purchases of company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
KORU Medical Systems, Inc. President and Chief Commercial Officer Adam R. Kalbermatten reported open-market purchases of company common stock. On one date, he bought 7,500 shares at $3.93 per share and 5,000 shares at $3.96 per share, for a total of 12,500 shares acquired directly.
Insider Trade Summary
Net Buyer: 12,500 shares
Net Buy
2 txns
Insider
KALBERMATTEN ADAM R
Role
President-Chief Commercial Off
Bought
12,500 shs ($49K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $3.96 | $20K |
| Purchase | Common Stick | 7,500 | $3.93 | $29K |
Holdings After Transaction:
Common Stock — 305,000 shares (Direct);
Common Stick — 312,500 shares (Direct)
Key Figures
Shares purchased: 12,500 shares
First purchase size: 7,500 shares
First purchase price: $3.93/share
+4 more
7 metrics
Shares purchased
12,500 shares
Total open-market purchases reported for the date
First purchase size
7,500 shares
Non-derivative common stock bought at $3.93 per share
First purchase price
$3.93/share
Open-market purchase of 7,500 common shares
Second purchase size
5,000 shares
Non-derivative common stock bought at $3.96 per share
Second purchase price
$3.96/share
Open-market purchase of 5,000 common shares
Buy transactions count
2 transactions
Total open-market purchase entries in the Form 4
Net buy direction
net-buy of 12,500 shares
Transaction summary for the reporting period
Key Terms
open-market purchase, Common Stock, non-derivative, transaction code "P"
4 terms
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
non-derivative financial
""transaction_type": "non-derivative""
transaction code "P" financial
""transaction_code": "P""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did KRMD executive Adam Kalbermatten report?
Adam Kalbermatten reported buying KORU Medical Systems common stock in the open market. He made two direct purchases totaling 12,500 shares at prices between $3.93 and $3.96 per share, as disclosed in a Form 4 insider filing.
At what prices did the KRMD insider purchase KORU Medical stock?
The KRMD insider purchased KORU Medical Systems common stock at $3.93 and $3.96 per share. Specifically, he bought 7,500 shares at $3.93 and 5,000 shares at $3.96, with both transactions categorized as open-market purchases of non-derivative common stock.
Were the KRMD insider transactions open-market purchases or derivative exercises?
The KRMD insider transactions were open-market purchases of non-derivative common stock. The Form 4 classifies both trades with transaction code “P” and describes them as open-market purchases, with no associated options, warrants, or other derivative securities reported in the filing.
Does the KRMD Form 4 show any insider stock sales by Adam Kalbermatten?
The Form 4 for Adam Kalbermatten shows only purchases, not sales. It reports two buy transactions totaling 12,500 shares, and the transaction summary lists zero sell shares, indicating a net-buy position for this reporting period.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates